Intellego Technologies [Intellego] announced in October 2025 that its subsidiary Yuvio Technologies [Yuvio] had received an order from MoveoMed GmbH [MoveoMed] valued at EUR 22 million for UV-C disinfection devices to be delivered during 2025. Today MoveoMed informed Intellego, that the order is cancelled.
As a result of the independent forensic investigation that KPMG is conducting in connection with the criminal suspicions directed against the company's former CEO, Intellego has received information that the terms of the order to Yuvio, including payment and delivery terms, were falsified.
“Since the previous CEO was arrested on November 18th, we are turning every stone and all transactions are being reviewed”, says Jacob Laurin, Acting CEO Intellego Technologies AB.
Further information on Intellego’s transactions will follow the independent report from KPMG that will be presented during January, 2026.